The results of Novo Nordisk’s phase 1 trials shows the oral weight loss pill could be more effective than semaglutide.

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Medical researchers have found that people who take the semaglutide-based drugs Ozempic and Wegovy may be less likely to die ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

Several other weight-loss pills are also in late-stage trials ... of safety and that we will continue to see the benefits that we’ve seen already with semaglutide, potentially even on a grander scale, ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

Pfizer is removing its Oxbryta pill for sickle cell disease from all markets globally due to safety risks, including deaths.

The future of oral weight loss medication looks bright. Drug manufacturer Novo Nordisk announced a new experimental ...

About half or more patients taking semaglutide, a glucagon-like peptide ... their once-weekly subcutaneous injections or daily oral pills at 12 months, but longer-acting formulations may increase ...

The most advanced of these pills include a form of semaglutide, the active ingredient in Ozempic and Wegovy, being developed by Novo Nordisk. The Danish drugmaker reported last year that a late ...